Niels Sharman

Investment Manager

Niels Sharman

Investment Manager

Niels Sharman has been supporting the life science investment team since November 2020. He holds a bachelor degree in biology from the Ludwig-Maximilians-University Munich and a master in management from the Technical University Munich. In the past he gained experience in the pharmaceutical industry and worked for two biotech start-ups.

Contact

Telefon:
+49 – (0) 228 – 82300 – 187

Portfolio

Posts & mentions

Press
31. March 2022

Improving ARDS treatment with digital twins: Ebenbuild secures seed financing round led by Bayern Kapital and High-Tech Gründerfonds

Munich/Bonn/Landshut, 31 March 2022 - Software start-up Ebenbuild has secured seven-figure funding as part of a seed financing round. Alongside lead investors High-Tech Gründerfonds and Bayern Kapital, the venture and growth capital organisation of the state of Bavaria, a number of well-known business angels also invested in the Munich-based HealthTech start-up, with the funding amounting to €2.5 million. Ebenbuild develops personalised lung simulation models based on patient data. These
 
Press
27. January 2022

Altavo completes Seed Financing Round for the Development of AI-based Voice Prosthetics

Altavo GmbH, a speech technology and medical technology spin-off of TU Dresden, successfully completed its seed financing round in December 2021. A consortium led by High-Tech Gründerfonds (HTGF) is investing in the development of Altavo’s AI-based speech prosthesis. Altavo is developing a non-invasive prosthesis aimed at restoring an individual, natural-sounding voice for people who have lost their voice, for example, due to laryngectomy. The approach is based on non-invasive radar se
 
Press
26. January 2022

UK-based health tech company bioniq acquires LOEWI

LOEWI is a scientific spin-off of the TU München, which provides tailor-made nutrients based on your blood work and lifestyleThe acquisition is a continuation of bioniq´s global expansion and accelerates the European market presenceHigh-Tech Gründerfonds invested in LOEWI´s seed round in 2020   London, January 26th – Through the acquisition to the UK-based health tech company bioniq, High-Tech Gründerfonds (HTGF) has sold its stake in LOEWI, a scientific spin-off of the TU
 
Press
23. June 2021

Spacing rules in the brain: Novel compounds that act as molecular spacers in the brain prevent neurodegeneration

High-Tech Gründerfonds (HTGF) provides seed funding for the neuro start-up FundaMental Pharma GmbH (FMP), a spin-off of the Interdisciplinary Center for Neuroscience (IZN) at Heidelberg University. FMP scientists have discovered a "death complex" in neurons whose activation leads to neurodegeneration. With the identification of a novel class of drugs, the FMP has also laid the foundation for successfully combating life-threatening neurological diseases. The financing makes it now possible t